# INTIBIA Pivotal Study

> **NCT05250908** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Coloplast A/S** · enrollment: 208 (actual)

## Conditions studied

- Urinary Incontinence, Urge
- Urinary Bladder, Overactive
- Urinary Bladder Diseases
- Urologic Diseases
- Lower Urinary Tract Symptoms
- Urological Manifestations

## Interventions

- **DEVICE:** INTIBIA Therapeutic
- **DEVICE:** INTIBIA Non-Therapeutic

## Key facts

- **NCT ID:** NCT05250908
- **Lead sponsor:** Coloplast A/S
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-03-07
- **Primary completion:** 2025-05-12
- **Final completion:** 2026-06-27
- **Target enrollment:** 208 (ACTUAL)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05250908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05250908, "INTIBIA Pivotal Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05250908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*